iscalimab,ianalumab,Belimumab,rituximab
novartis,GSK
['twinss', 'omg', 'iscalimab']
new promising agents in sjogrens syndrome!
#eular2023 
Rheumatologist and life long learner 🤓. Citizen of the world.Special shoutout to my students and patients, you got this💪🏽. 😷